13F 申報指南13F 觀念全攻略
什麼是 SEC Form 13F 申報？美股機構大戶持股全攻略
完整解讀 Form 13F 申報規範、1 億美元門檻與 45 天延遲申報機制，學會如何追蹤頂級對沖基金與機構法人持倉動向。
AlphaSMO 權威研究指南閱讀專題
CIK: 0001920938
申報總市值
US$27.0億
US$27.0億
88 檔
19.3%
Braidwell LP 在 Q1 2026 季度的美股部位總計估值為 US$27.0億，分散於 88 個持倉標的之中，反映其市場參與廣度與投資規模。
觀察 Q1 2026 的資金脈絡，Braidwell LP 在獲利結算 16 檔個股的同時，將資本重新部署至 31 檔新選標的，展現主動管理機構的輪動節奏。
從部位權重觀察，前 5 大標的（包含 CAI, GH 1.25 02-15-31, RGEN 1 12-15-28）累計市值佔比達 19.3%，是驅動 Braidwell LP 該季度整體投資組合績效表現的核心支柱。
| # | 代號 | 標的名稱 | 資產子類別 | 佔比 | 佔比變動 | 持倉量變化 | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | CAI | Caris Life Sciences Inc | 股票-其他 | 4.78% | +0.66% | +2.47% | |
| 2 | GH 1.25 02-15-31債券 | Guardant Health Inc | 債券 | 3.42% | -3.42% | EXIT | |
| 3 | RGEN 1 12-15-28債券 | Repligen CORP | 債券 | 3.29% | -2.68% | — | |
| 4 | NEO 0.25 01-15-28債券 | Neogenomics Inc | 債券 | 3.06% | -2.44% | — | |
| 5 | NBIX | Neurocrine Biosciences Inc | 股票-醫療保健 | 2.87% | -0.77% | -13.23% | |
| 6 | GKOS | Glaukos CORP | 股票-醫療保健 | 2.74% | +0.32% | -17.19% | |
| 7 | 260 | Centessa Pharmaceuticals-adr | 股票-其他 | 2.63% | -2.63% | EXIT | |
| 8 | XENE | Xenon Pharmaceuticals Inc | 股票-其他 | 2.60% | -0.07% | -26.66% | |
| 9 | DNTH | Dianthus Therapeutics Inc | 股票-其他 | 2.52% | -0.38% | -29.40% | |
| 10 | EWTX | Edgewise Therapeutics Inc | 股票-其他 | 2.47% | +0.53% | -54.95% | |
| 11 | IRTC | Irhythm Holdings Inc | 股票-醫療保健 | 2.40% | +0.48% | +180.75% | |
| 12 | NUVL | Nuvalent Inc-a | 股票-其他 | 2.39% | -2.39% | EXIT | |
| 13 | KOD | Kodiak Sciences Inc | 股票-其他 | 2.31% | +0.27% | -12.26% | |
| 14 | CGON | Cg Oncology Inc | 股票-其他 | 2.22% | -2.22% | EXIT | |
| 15 | ATEC 0.75 03-15-30債券 | Alphatec Holdings Inc | 債券 | 2.11% | +0.34% | — | |
| 16 | ARGX | Argenx Se - Adr | 股票-醫療保健 | 2.07% | -1.46% | +173.93% | |
| 17 | HNGE | Hinge Health Inc-a | 股票-其他 | 1.87% | +2.21% | +11.54% | |
| 18 | ACAD | Acadia Pharmaceuticals Inc | 股票-醫療保健 | 1.84% | -0.30% | +21.61% | |
| 19 | GLUE | Monte Rosa Therapeutics Inc | 股票-其他 | 1.76% | +0.43% | +238.13% | |
| 20 | KRYS | Krystal Biotech Inc | 股票-醫療保健 | 1.57% | +0.20% | -9.74% | |
| 21 | SYRE | Spyre Therapeutics Inc | 股票-其他 | 1.57% | +1.32% | -42.93% | |
| 22 | GH | Guardant Health Inc | 股票-醫療保健 | 1.54% | -0.72% | — | |
| 23 | TMO | Thermo Fisher Scientific Inc | 股票-醫療保健 | 1.52% | +0.14% | +15.10% | |
| 24 | GENB | Generate Biomedicines Inc | 股票-其他 | 1.50% | +0.55% | — | |
| 25 | MBX | Mbx Biosciences Inc | 股票-其他 | 1.49% | -0.04% | +46.52% | |
| 26 | BTSG | Brightspring Health Services | 股票-其他 | 1.44% | +0.10% | -14.99% | |
| 27 | CLDX | Celldex Therapeutics Inc | 股票-其他 | 1.43% | -0.83% | -27.02% | |
| 28 | NEO | Neogenomics Inc | 股票-醫療保健 | 1.39% | +1.26% | +21.25% | |
| 29 | APGE | Apogee Therapeutics Inc | 股票-其他 | 1.34% | -1.34% | EXIT | |
| 30 | DRUG | Bright Minds Biosciences Inc | 股票-其他 | 1.31% | -0.05% | +66.39% | |
| 31 | CDNA | Caredx Inc | 股票-其他 | 1.26% | +0.03% | +37.09% | |
| 32 | ISRG | Intuitive Surgical Inc | 股票-醫療保健 | 1.19% | -0.16% | -7.34% | |
| 33 | INSP | Inspire Medical Systems Inc | 股票-醫療保健 | 1.17% | -0.05% | +25.27% | |
| 34 | PEN | Penumbra Inc | 股票-醫療保健 | 1.15% | -1.15% | EXIT | |
| 35 | TMDX | Transmedics Group Inc | 股票-醫療保健 | 1.09% | +0.41% | +4.46% | |
| 36 | SLNOEUR | Soleno Therapeutics Inc | 股票-其他 | 1.07% | -1.07% | EXIT | |
| 37 | DYN | Dyne Therapeutics Inc | 股票-其他 | 1.02% | -0.26% | +13.78% | |
| 38 | MRVI | Maravai Lifesciences Hldgs-a | 股票-其他 | 0.97% | +1.04% | +22.59% | |
| 39 | ILMN | Illumina Inc | 股票-醫療保健 | 0.94% | -0.94% | EXIT | |
| 40 | KYMR | Kymera Therapeutics Inc | 股票-其他 | 0.94% | +0.66% | -25.69% | |
| 41 | BMRN | Biomarin Pharmaceutical Inc | 股票-醫療保健 | 0.94% | -0.94% | EXIT | |
| 42 | NRIX | Nurix Therapeutics Inc | 股票-其他 | 0.91% | +0.24% | -19.83% | |
| 43 | RYTM | Rhythm Pharmaceuticals Inc | 股票-其他 | 0.90% | +0.67% | — | |
| 44 | DHR | Danaher CORP | 股票-醫療保健 | 0.88% | +0.18% | +17.85% | |
| 45 | ✓ | Establishment Labs Holdings In | 股票-其他 | 0.88% | -0.88% | EXIT | |
| 46 | TECX | Tectonic Therapeutic Inc | 股票-其他 | 0.87% | -0.11% | -8.67% | |
| 47 | NTRA | Natera Inc | 股票-醫療保健 | 0.86% | -0.06% | +15.70% | |
| 48 | CRVS | Corvus Pharmaceuticals Inc | 股票-其他 | 0.86% | +0.32% | — | |
| 49 | FULC | Fulcrum Therapeutics Inc | 股票-其他 | 0.80% | -0.80% | EXIT | |
| 50 | ✓ | Zura Bio LTD | 股票-其他 | 0.79% | +0.08% | +25.42% |
| # | 代號 | 標的名稱 | 佔比變動 | 持倉量變化 | 異動類型 |
|---|---|---|---|---|---|
| 1 | GLUE | Monte Rosa Therapeutics Inc | +1.3% | +238.13% | 加碼 |
| 2 | ARGX | Argenx Se - Adr | +1.2% | +173.93% | 加碼 |
| 3 | IRTC | Irhythm Holdings Inc | +1.2% | +180.75% | 加碼 |
| 4 | 260 | Centessa Pharmaceuticals-adr | +0.9% | -9.21% | 減碼 |
| 5 | DNTH | Dianthus Therapeutics Inc | +0.8% | -29.40% | 減碼 |
| 6 | DRUG | Bright Minds Biosciences Inc | +0.5% | +66.39% | 加碼 |
| 7 | MBX | Mbx Biosciences Inc | +0.5% | +46.52% | 加碼 |
| 8 | KOD | Kodiak Sciences Inc | +0.5% | -12.26% | 減碼 |
| 9 | CDNA | Caredx Inc | +0.3% | +37.09% | 加碼 |
| 10 | ✓ | Zura Bio LTD | +0.3% | +25.42% | 加碼 |
| 11 | TECX | Tectonic Therapeutic Inc | +0.3% | -8.67% | 減碼 |
| 12 | NEO 0.25 01-15-28債券 | Neogenomics Inc | +0.2% | — | 不變 |
| 13 | MRVI | Maravai Lifesciences Hldgs-a | +0.1% | +22.59% | 加碼 |
| 14 | DYN | Dyne Therapeutics Inc | +0.1% | +13.78% | 加碼 |
| 15 | ACAD | Acadia Pharmaceuticals Inc | +0.1% | +21.61% | 加碼 |
| 16 | PEN | Penumbra Inc | +0.1% | -4.36% | 減碼 |
| 17 | SRZN | Surrozen Inc | 0% | -15.72% | 減碼 |
| 18 | NTRA | Natera Inc | 0% | +15.70% | 加碼 |
| 19 | KNSA | Kiniksa Pharmaceuticals International, plc | 0% | -13.16% | 減碼 |
| 20 | TMO | Thermo Fisher Scientific Inc | 0% | +15.10% | 加碼 |
| 21 | XFOR | X4 Pharmaceuticals Inc | 0% | -2.85% | 減碼 |
| 22 | BTSG | Brightspring Health Services | 0% | -14.99% | 減碼 |
| 23 | DHR | Danaher CORP | 0% | +17.85% | 加碼 |
| 24 | XENE | Xenon Pharmaceuticals Inc | 0% | -26.66% | 減碼 |
| 25 | KRYS | Krystal Biotech Inc | 0% | -9.74% | 減碼 |
| 26 | LUNG | Pulmonx CORP | 0% | — | 不變 |
| 27 | KIDS | Orthopediatrics CORP | 0% | — | 不變 |
| 28 | APGE | Apogee Therapeutics Inc | -0.1% | -16.76% | 減碼 |
| 29 | HNGE | Hinge Health Inc-a | -0.1% | +11.54% | 加碼 |
| 30 | CMPX | Compass Therapeutics Inc | -0.1% | -29.48% | 減碼 |
| 31 | SYRE | Spyre Therapeutics Inc | -0.1% | -42.93% | 減碼 |
| 32 | TMDX | Transmedics Group Inc | -0.1% | +4.46% | 加碼 |
| 33 | GRAL | Grail Inc | -0.1% | — | 不變 |
| 34 | CLDX | Celldex Therapeutics Inc | -0.2% | -27.02% | 減碼 |
| 35 | KYMR | Kymera Therapeutics Inc | -0.2% | -25.69% | 減碼 |
| 36 | ILMN | Illumina Inc | -0.2% | -15.00% | 減碼 |
| 37 | BMRN | Biomarin Pharmaceutical Inc | -0.2% | -17.37% | 減碼 |
| 38 | EOLS | Evolus Inc | -0.2% | — | 不變 |
| 39 | RGEN | Repligen CORP | -0.2% | -41.92% | 減碼 |
| 40 | RGEN 1 12-15-28債券 | Repligen CORP | -0.3% | — | 不變 |
| 41 | NUVL | Nuvalent Inc-a | -0.3% | -14.73% | 減碼 |
| 42 | CGON | Cg Oncology Inc | -0.3% | -47.35% | 減碼 |
| 43 | HROW | Harrow Inc | -0.3% | -47.03% | 減碼 |
| 44 | FULC | Fulcrum Therapeutics Inc | -0.3% | +2.41% | 加碼 |
| 45 | ISRG | Intuitive Surgical Inc | -0.3% | -7.34% | 減碼 |
| 46 | ✓ | Engene Holdings Inc | -0.3% | -21.54% | 減碼 |
| 47 | NEO | Neogenomics Inc | -0.4% | +21.25% | 加碼 |
| 48 | NRIX | Nurix Therapeutics Inc | -0.4% | -19.83% | 減碼 |
| 49 | INSP | Inspire Medical Systems Inc | -0.4% | +25.27% | 加碼 |
| 50 | NBIX | Neurocrine Biosciences Inc | -0.5% | -13.23% | 減碼 |
根據 SEC 官方 Form 13F 申報備案，Braidwell LP 在 Q1 2026 季度的美股持倉總市值約為 US$27.0億，共申報了 88 個公開持股部位。
在 Q1 2026 季度，Braidwell LP 按市值排列的前三大核心持股分別為：CAI (4.8%)、GH 1.25 02-15-31 (3.4%)、RGEN 1 12-15-28 (3.3%)。其中最大持股部位 CAI 佔據整體投資組合約 4.8% 的權重。
精選 AlphaSMO 大戶持股與內部人交易深度分析，提升投資決策勝率
完整解讀 Form 13F 申報規範、1 億美元門檻與 45 天延遲申報機制，學會如何追蹤頂級對沖基金與機構法人持倉動向。
本季最大新建倉標的
ATEC 0.75 03-15-30
市值: US$6339.0萬
本季最大獲利了結 / 清倉標的
IRTC 1.5 09-01-29
前期市值: US$7280.0萬
在 Q1 2026 季度中，Braidwell LP 共進行了 98 項持倉異動，包含新建倉 31 個部位、加碼 19 個部位、減碼 32 個部位以及清倉 16 個部位。 其中最大新建倉標的為 ATEC 0.75 03-15-30。 本季清倉部位包含 IRTC 1.5 09-01-29。
本頁面所有持股數據均直接同步自美國證券交易委員會（SEC）EDGAR 官方系統之 13F-HR / 13F-HR/A 季度申報文件。AlphaSMO 透過機器解析 CUSIP 與個股對照，提供 100% 精準對齊的歷史時序數據集，並支援 Schema.org 結構化資料格式。
解析公司高管、董事與 10% 大股東之 Form 4 內部人交易申報，掌握高管自家股票買賣第一手訊號。
深入剖析 5% 股益申報門檻、13D 與 13G 之差異，以及最新 SEC 申報時程規範，洞察機構法人的激進投資動向。